Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.
Journal article
Ali M. et al, (2024), Clin exp immunol
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.
Journal article
Thornhill JP. et al, (2024), Aids, 38, 679 - 688
Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents.
Journal article
Sampson OL. et al, (2024), Front immunol, 15
Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.
Journal article
Zacharopoulou P. et al, (2024), Front immunol, 15
Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.
Journal article
Kopycinski J. et al, (2023), Sci rep, 13
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Journal article
Barnes E. et al, (2023), Nat med, 29, 1760 - 1774
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery
Preprint
Ali M. et al, (2023)
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses.
Journal article
Dijokaite-Guraliuc A. et al, (2023), Cell rep, 42
Paediatric HIV slow-progression is associated with early CD8+ T-cell PD-1 expression and a stem-like phenotype.
Journal article
Adriano Vieira V. et al, (2023), Jci insight
Analysis of broadly neutralising antibody resistance in adolescents and young people living with HIV
Conference paper
Zacharopoulou P. et al, (2023), Hiv medicine, 24, 35 - 35
Learning patterns of HIV-1 co-resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning
Preprint
Igiraneza AB. et al, (2023)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.
Journal article
Murray SM. et al, (2022), Nat rev immunol, 1 - 13
A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117.
Journal article
Zacharopoulou P. et al, (2022), Curr opin hiv aids, 17, 352 - 358
Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
Journal article
Fidler S. et al, (2022), Clin infect dis
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Journal article
Tuekprakhon A. et al, (2022), Cell
An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.
Journal article
Tipoe T. et al, (2022), Curr opin hiv aids, 17, 162 - 170
An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.
Journal article
Tipoe T. et al, (2022), Curr opin hiv aids
BreakAlign: a Perl program to align chimaeric (split) genomic NGS reads and allow visual confirmation of novel retroviral integrations.
Journal article
Marchi E. et al, (2022), Bmc bioinformatics, 23
The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial.
Journal article
Lee MJ. et al, (2022), Trials, 23